ESC Atlas of Cardiology
The ESC Atlas of Cardiology is a unique, comprehensive database including 300 CVD-related variables from 57 countries across Europe and the Mediterranean basin.
ESC Atlas has been identifying, mapping and analysing the status of healthcare systems from a cardiovascular perspective since 2016. It highlights trends, disparities and inequalities in the burden of CVD across its 57 member countries.
You will find data ranging from socio-demographics features, demand-side risk factors, and CVD epidemiology burden (mortality and morbidity), to supply of cardiac services, such as human and capital resources, services provided, and selected procedures performed.
The ESC Atlas provides valuable insights for evidence-based health policy in cardiology, as well as peer reviewed data for academics, clinician, the healthcare industry and others requiring high quality data from a trusted source.
The ESC Atlas of Cardiology could not exist without the data shared by its 57 National Cardiac Societies. Thank you to all those who help make this ambitious cardiovascular data centre a reality.
ESC Atlas of Cardiology variables
Click on the category to see a list of all variables within that category
No results found.
-
National sociodemographic characteristics
- Age dependency ratio, old (% of working-age population)
- Annual population growth rate (%)
- Fertility rate, total (births per woman)
- Gini index (World Bank estimate)
- Hospital beds (per 1,000 people)
- Life expectancy at birth, female (years)
- Life expectancy at birth, male (years)
- Life expectancy at birth, total (years)
- Median age by country. UN estimates
- Mortality rate, infant (per 1,000 live births)
- Physicians (per 1,000 people)
- Total population
- Unemployment, female (% of female labor force) (modeled ILO estimate)
- Unemployment, male (% of male labor force) (modeled ILO estimate)
- Unemployment, total (% of total labor force) (modeled ILO estimate)
- Urban population (% of total population)
- Economics and health expenditure
-
Risk factors
- Enviromental risk factors
-
Lifestyle risk factors
- Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (female)
- Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (male)
- Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (total)
- Daily smoking, both (% population aged 15+, age-standardized)
- Daily smoking, female (% population aged 15+, age-standardized)
- Daily smoking, male (% population aged 15+, age-standardized)
- Estimated intake of fruit in adults aged 25 and older (g/day)
- Estimated intake of sodium in adults aged 25 and older (g/day)
- Estimated intake of sugar-sweetened beverages in adults aged 25 and older (g/day)
- Estimated intake of vegetables in adults aged 25 and older (g/day)
- Heavy episodic drinking (last 30 days), both (% population aged 15+, age-standardized)
- Heavy episodic drinking (last 30 days), female (% population aged 15+, age-standardized)
- Heavy episodic drinking (last 30 days), male (% population aged 15+, age-standardized)
- Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) 2016 (female)
- Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) 2016 (male)
- Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) 2016 (total)
-
Clinical risk factors
- Mean HDL cholesterol (mmol/L) (female)
- Mean HDL cholesterol (mmol/L) (male)
- Mean non-HDL cholesterol (mmol/L) (female)
- Mean non-HDL cholesterol (mmol/L) (male)
- Mean systolic blood pressure (age-standardized estimate) 18+ years (female)
- Mean systolic blood pressure (age-standardized estimate) 18+ years (male)
- Mean total cholesterol (mmol/L) (female)
- Mean total cholesterol (mmol/L) (male)
- Obesity (BMI >= 30), both (% population aged 18+, age-standardized)
- Obesity (BMI >= 30), female (% population aged 18+, age-standardized)
- Obesity (BMI >= 30), male (% population aged 18+, age-standardized)
- Raised blood pressure, both (% population aged 18+, age-standardized)
- Raised blood pressure, female (% population aged 18+, age-standardized)
- Raised blood pressure, male (% population aged 18+, age-standardized)
-
Cardiovascular disease morbidity
- CVD incidence, Both
- CVD incidence, Female
- CVD incidence, Male
- CVD prevalence, Both
- CVD prevalence, Female
- CVD prevalence, Male
- Calcific aortic valve disease incidence, Both
- Calcific aortic valve disease incidence, Female
- Calcific aortic valve disease incidence, Male
- Calcific aortic valve disease prevalence, Both
- Calcific aortic valve disease prevalence, Female
- Calcific aortic valve disease prevalence, Male
- DALYs due to atrial fibrillation, Both
- DALYs due to atrial fibrillation, Female
- DALYs due to atrial fibrillation, Male
- DALYs due to peripheral arterial disease, Both
- DALYs due to peripheral arterial disease, Female
- DALYs due to peripheral arterial disease, Male
- DALYs due to CVD, Both
- DALYs due to CVD, Female
- DALYs due to CVD, Male
- DALYs due to IHD, Both
- DALYs due to IHD, Female
- DALYs due to IHD, Male
- DALYs due to air pollution, Both
- DALYs due to air pollution, Female
- DALYs due to air pollution, Male
- DALYs due to calcific aortic valve disease, Both
- DALYs due to calcific aortic valve disease, Female
- DALYs due to calcific aortic valve disease, Male
- DALYs due to degenerative mitral valve disease, Both
- DALYs due to degenerative mitral valve disease, Female
- DALYs due to degenerative mitral valve disease, Male
- DALYs due to rheumatic heart disease, Both
- DALYs due to rheumatic heart disease, Female
- DALYs due to rheumatic heart disease, Male
- DALYs due to stroke, Both
- DALYs due to stroke, Female
- DALYs due to stroke, Male
- Degenerative mitral valve disease incidence, Both
- Degenerative mitral valve disease incidence, Female
- Degenerative mitral valve disease incidence, Male
- Degenerative mitral valve disease prevalence, Both
- Degenerative mitral valve disease prevalence, Female
- Degenerative mitral valve disease prevalence, Male
- IHD incidence, Both
- IHD incidence, Female
- IHD incidence, Male
- IHD prevalence, Both
- IHD prevalence, Female
- IHD prevalence, Male
- Incidence of atrial fibrillation, Both
- Incidence of atrial fibrillation, Female
- Incidence of atrial fibrillation, Male
- Incidence of peripheral arterial disease, Both
- Incidence of peripheral arterial disease, Female
- Incidence of peripheral arterial disease, Male
- Prevalence of atrial fibrillation, Both
- Prevalence of atrial fibrillation, Female
- Prevalence of atrial fibrillation, Male
- Prevalence of peripheral arterial disease, Both
- Prevalence of peripheral arterial disease, Female
- Prevalence of peripheral arterial disease, Male
- Rheumatic heart disease incidence, Both
- Rheumatic heart disease incidence, Female
- Rheumatic heart disease incidence, Male
- Rheumatic heart disease prevalence, Both
- Rheumatic heart disease prevalence, Female
- Rheumatic heart disease prevalence, Male
- Stroke incidence, Both
- Stroke incidence, Female
- Stroke incidence, Male
- Stroke prevalence, Both
- Stroke prevalence, Female
- Stroke prevalence, Male
-
Cardiovascular disease mortality
- Deaths due to cardiovascular diseases, female (crude rate per 100000)
- Deaths due to cardiovascular diseases, female (per 100000, age-standardized)
- Deaths due to cardiovascular diseases, male (crude rate per 100000)
- Deaths due to cardiovascular diseases, male (per 100000, age-standardized)
- Premature deaths due to cardiovascular diseases, female (crude rate per 100000)
- Prenature deaths due to cardiovascular diseases, male (crude rate per 100000)
-
Cardiovascular healthcare delivery
- Cardiological specialists
- Diagnostic coronary angiography
-
Electrophysiology
- Ablations to correct heart rhythm disorders (per million people)
- Cardiac resynchronization therapy device (CRT-D and CRT-P) implantations (per million people)
- Hospitals implanting cardiac resynchronization therapy (CRT) devices (per million people)
- Hospitals implanting cardioverter defibrillators (ICDs) (per million people)
- Hospitals implanting pacemakers (per million people)
- Hospitals undertaking electrophysiology procedures (per million people)
- Implantable cardioverter defibrillator (ICD) implantations (per million people)
- Pacemaker implantations (per million people)
-
Interventional cardiology infrastructure
- Hospital with cath labs (per million people)
- Hospitals with cath labs on 24 hours/7 days service (per million people)
- Hospitals with cath labs performing structural heart disease interventions in children (per million people)
- Hospitals with cath labs performing structural heart disease interventions in the adult (per million people)
-
Interventional cardiology procedures
- Percutaneous aortic valve implantation (TAVI) (per million people)
- Percutaneous coronary interventions (PCI) (per million people)
- Percutaneous mitral valve interventions (per million people)
- Percutaneous tricuspid valve interventions (per million people)
- Primary percutaneous coronary intervention (pPCI) (per million people)
-
Cardiac surgery
- Coronary artery bypass graft surgery (CABG) (per million people)
- Heart transplantations (per million people)
- Hospitals with cardiac surgery (per million people)
- Hospitals with cardiac transplantation programmes (per million people)
- Left, right and both ventricular assist device implantations (per million people)
- Surgical aortic valve interventions (repairs and replacements) (per million people)
- Surgical interventions in congenital heart disease (per million people)
- Congenital heart disease
- Cardiac capital resources
